Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic pulmonary embolism

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalBlood
Year 2012

Cet article est inclus dans 2 Systematic reviews Systematic reviews (2 references)

This article is part of the following publication threads:
  • EINSTEIN PE [Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism] (12 documents)
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 1979940e6041e728f4028c92fe1603d53a67cb8d
First added on: May 17, 2016